HUTCHMED (China) Ltd banner
H

HUTCHMED (China) Ltd
F:H7T1

Watchlist Manager
HUTCHMED (China) Ltd
F:H7T1
Watchlist
Price: 10.3 EUR -6.36% Market Closed
Market Cap: €1.8B

Wall St Price Targets

H7T1 Price Targets Summary
HUTCHMED (China) Ltd

Wall Street analysts forecast H7T1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for H7T1 is 16.53 EUR with a low forecast of 11.03 EUR and a high forecast of 23.1 EUR.

Lowest Forecast
Price Target
11.03 EUR
7% Upside
Average Forecast
Price Target
16.53 EUR
61% Upside
Highest Forecast
Price Target
23.1 EUR
124% Upside
HUTCHMED (China) Ltd Competitors:
Price Targets
SUDEEPPHRM
Sudeep Pharma Ltd
-41% Downside

Revenue
Forecast

8% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
8% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 29%.

Gross Profit
Forecast

6% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
6% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 4 years is 26%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Pre-Tax Income
Forecast

35% / Year
Past Growth
-38% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
35% / Year
Past Growth
-38% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 35%. The projected CAGR for the next 3 years is -38%.

Net Income
Forecast

45% / Year
Past Growth
-23% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
45% / Year
Past Growth
-23% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

Over the last 13 years, the compound annual growth rate for Net Income has been 45%. The projected CAGR for the next 4 years is -23%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is H7T1's stock price target?
Price Target
16.53 EUR

According to Wall Street analysts, the average 1-year price target for H7T1 is 16.53 EUR with a low forecast of 11.03 EUR and a high forecast of 23.1 EUR.

What is the Revenue forecast for HUTCHMED (China) Ltd?
Projected CAGR
29%

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 29%.

What is the Gross Profit forecast for HUTCHMED (China) Ltd?
Projected CAGR
26%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 4 years is 26%.

What is the Pre-Tax Income forecast for HUTCHMED (China) Ltd?
Projected CAGR
-38%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 35%. The projected CAGR for the next 3 years is -38%.

What is the Net Income forecast for HUTCHMED (China) Ltd?
Projected CAGR
-23%

Over the last 13 years, the compound annual growth rate for Net Income has been 45%. The projected CAGR for the next 4 years is -23%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett